MediFind Announced as Finalist for Reuter’s Pharma Awards USA: Most Valuable Service or Digital Therapy

By: Sarah Larcker
article thumbnail

The Reuters Events’ Pharma Awards USA focus on what really matters: value for patients and customers. Recognizing innovative and meaningful approaches: this is the work worth applauding. The awards focus on initiatives that deliver outcomes, restore pharma’s reputation and celebrate real achievements.

Specifically, the Most Valuable Service or Digital Therapy category focuses on initiatives that go beyond the pill, providing a holistic service or solution that provides significant benefit to patients.

The formal awards ceremony is scheduled for December 7-9, 2020. Read more about the award and the other finalists here.

Relevant Articles

  • Articles
    Wellness Tips for Rare Disease Caregivers 

    Tending to your own needs may be the last thing on your mind. But taking time for yourself can actually make you a better caregiver.

    article thumbnail
  • Treatment Advances
    Age-Related Macular Degeneration Treatment Overview

    There is currently no cure for macular degeneration. Macular degeneration is a chronic, progressive disease. Patients with early age-related macular degeneration that are treated early may not progress to advanced vision loss. Treatment for macular degeneration is focused on slowing progression of the disease. There are two types of macular degeneration: Dry macular degeneration, is…

    article thumbnail
  • Uncategorized
    Terms and conditions

    These Terms of Use were last updated on August 08, 2023 MediFind and its affiliates (“MediFind”) operate this website, (the “Site”) and the services related to or offered on the Site (hereinafter, the “Services”). MediFind’s Services may include, without limitation, provision of content, software tools, applications, bulletin and message boards, chat areas, forums, and/or community-based functionalities. The Site and Services are funded, and MediFind may earn income, from advertising, sponsored content, affiliate program commissions as well as other sources. These Terms of Use (“TOU”) govern your use of the Site and Services that are provided by MediFind in connection with…

    article thumbnail